Company profile
Scienture Holdings, Inc.
NASDAQ: SCNX · Healthcare · Medical - Healthcare Information Services
#942 of 1,418 Healthcare companies by revenuetop-decile growth
EA Score
50DFH 46DQ 60GM 46SS 45
v0.1 · 65/100 weight · provisional
↑ revenue growth (YoY), balance-sheet leverage · ↓ operating margin, net margin
Methodology →Revenue TTM
$477.7k
Rev growth YoY (TTM)
+225.2%
Net income (FY)
-$41.5M
Employees
9
as of 2026-08-23
Market cap
$18.3M
as of 2026-08-23
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$431.6k$431.6k2025
Net income-$41.5M-$41.5M2025
Operating income-$42.6M-$42.6M2025
Total assets$84.2M$84.2M2025
Liabilities$14.1M$14.1M2025
Equity$70.1M$70.1M2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Scienture Holdings, Inc.’s revenue?
Scienture Holdings, Inc. booked $431.6k in FY2025 revenue, growing 216% year over year — faster than 90% of Healthcare companies we track, at a -9618.0% net margin.
Peers · Healthcare
Integrative Health Technologies, Inc.——Alternate Health Corp.——EnviroTechnologies International, Inc——Niki BioSolutions, Inc.31DAequus Pharmaceuticals Inc.——Amarantus BioScience Holdings, Inc.——Neighbors
Hillsborough →Key facts
CEOShankar Hariharan
SectorHealthcare
IndustryMedical - Healthcare Information Services
HeadquartersTampa, FL
ExchangeNASDAQ: SCNX
Employees9
IPO date2014-02-06
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.